Outcome after hepatic resection of solitary liver metastasis from colorectal cancer in the caudate lobe

World Journal of Surgery

Volumn 31, Issue 12, 2007, Pages 2378-2383

  Saiura, Akio ^a   Yamamoto, Junji ^a   Koga, Rintaro ^a   Kokudo, Norihiro ^b   Seki, Makoto ^a   Oya, Masatoshi ^a   Ueno, Masashi ^a   Kuroyanagi, Hiroya ^a   Fujimoto, Yoshiya ^a   Natori, Takeshi ^a   Yamaguchi, Toshiharu ^a   Muto, Tetsuichiro ^a  

^a CANCER INSTITUTE HOSPITAL   (Japan)

^b UNIVERSITY OF TOKYO   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; BLEEDING; CANCER SURVIVAL; COLORECTAL CANCER; CONTROLLED STUDY; FEMALE; HOSPITALIZATION; HUMAN; LIVER METASTASIS; LIVER RESECTION; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD; OPERATION DURATION; SURVIVAL RATE;

ADULT; AGED; AGED, 80 AND OVER; COLORECTAL NEOPLASMS; FEMALE; HEPATECTOMY; HUMANS; KAPLAN-MEIERS ESTIMATE; LIVER NEOPLASMS; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 36849085344     PISSN: 03642313     EISSN: 14322323     Source Type: Journal    
DOI: 10.1007/s00268-007-9250-9     Document Type: Article

References (20)

1. Cunningham D, Humblet Y, Siena S, et al (2004) Cetuximab monotherapy and cetuximab plus irinotecan in irinotecan-refractory metastatic colorectal cancer. N Engl J Med 351:337-345
2. Hurwitz H. (2004) Integrating the anti-VEGF-A humanized monoclonal antibody bevacizumab with chemotherapy in advanced colorectal cancer. Clin Colorectal Cancer 4(Suppl 2):S62-S68
3. Saltz LB, Meropol NJ, Loehrer PJ Sr, et al (2004) Phase II trial of cetuximab in patients with refractory colorectal cancer that expresses the epidermal growth factor receptor. J Clin Oncol 22:1201-1208
4. Aloia TA, Vauthey JN, Loyer EM, et al (2006) Solitary colorectal liver metastasis: resection determines outcome. Arch Surg 141:460-466; discussion 466-467
5. Minagawa M, Makuuchi M, Torzilli G, et al (2000) Extension of the frontiers of surgical indications in the treatment of liver metastases from colorectal cancer: long-term results. Ann Surg 231:487-499
6. Wagner JS, Adson MA, Van Heerden JA, et al (1984) The natural history of hepatic metastases from colorectal cancer: a comparison with resective treatment. Ann Surg 199:502-508
7. Belghiti J, Hiramatsu K, Benoist S, et al (2000) Seven hundred forty-seven hepatectomies in the 1990s: an update to evaluate the actual risk of liver resection. J Am Coll Surg 191:38-46
8. Fong Y, Fortner J, Sun RL, et al (1999) Clinical score for predicting recurrence after hepatic resection for metastatic colorectal cancer: analysis of 1001 consecutive cases. Ann Surg 230:309-308; discussion 318-321
9. Hawkins WG, DeMatteo RP, Cohen MS, et al (2005) Caudate hepatectomy for cancer: a single institution experience with 150 patients. J Am Coll Surg 200:345-352
10. Bartlett D, Fong Y, Blumgart LH (1996) Complete resection of the caudate lobe of the liver: technique and results. Br J Surg 83:1076-1081
11. Sarmiento JM, Que FG, Nagorney DM (2002) Surgical outcomes of isolated caudate lobe resection: a single series of 19 patients. Surgery 132:697-708; discussion 708-709
12. Tanaka K, Shimada H, Matsuo K, et al (2005) Surgical outcome of solitary colorectal metastasis to the hepatic caudate lobe. Br J Surg 92:847-848
13. Saiura A, Yamamoto J, Koga R, et al (2006) Usefulness of LigaSure for liver resection: analysis by randomized clinical trial. Am J Surg 192:41-45
14. Fortner JG, Silva JS, Golbey RB, et al (1984) Multivariate analysis of a personal series of 247 consecutive patients with liver metastases from colorectal cancer. I. Treatment by hepatic resection. Ann Surg 199:306-316
15. Hughes KS, Simon R, Songhorabodi S, et al (1986) Resection of the liver for colorectal carcinoma metastases: a multi-institutional study of patterns of recurrence. Surgery 100:278-284
16. Ekberg H, Tranberg KG, Anderson R, et al (1987) Pattern of recurrence in liver resection for colorectal secondaries. World J Surg 11:541-547
17. Cady B, Jenkins RL, Steele GD, et al (1998) Surgical margin in hepatic resection for colorectal metastasis: a critical and improvable determinant of outcome. Ann Surg 227:566-571
18. Yamamoto J, Sugihara K, Kosuge T, et al (1995) Pathologic support for limited hepatectomy in the treatment of liver metastases from colorectal cancer. Ann Surg 221:74-78
19. Elias D, Cavalcanti A, Sabourin JC, et al (1998) Results of 136 curative hepatectomies with a safety margin of less than 10 mm for colorectal metastases. J Surg Oncol 69:88-93
20. Stephenson KR, Steinberg SM, Hughes KS, et al (1988) Perioperative blood transfusions are associated with decreased time to recurrence and decreased survival after resection of colorectal liver metastases. Ann Surg 208:679-687